5AM Partners VI, LLC - 31 Jan 2024 Form 4 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Role
10%+ Owner
Signature
5AM Partners VI, LLC, By /s/ Kush Parmar, Managing Member
Issuer symbol
ELVN
Transactions as of
31 Jan 2024
Net transactions value
-$7,500,000
Form type
4
Filing time
02 Feb 2024, 16:29:43 UTC
Previous filing
28 Sep 2023
Next filing
16 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELVN Common Stock Sale $6,257,805 -417,187 -9.7% $15.00 3,888,992 31 Jan 2024 By 5AMVentures VI, L.P. F1
transaction ELVN Common Stock Sale $1,242,195 -82,813 -9.7% $15.00 771,983 31 Jan 2024 By 5AM Opportunities I, L.P. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VI and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. Each of Partners VI, Dr. Parmar and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein.
F2 The shares are directly held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are the managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Dr. Parmar and Mr. Schwab disclaims beneficial ownership of such shares, except to the extent of its or his respective pecuniary interest therein.